Stay updated on Fruquintinib and Sintilimab in Advanced Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Fruquintinib and Sintilimab in Advanced Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fruquintinib and Sintilimab in Advanced Solid Tumors Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The footer now displays revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-18T20:51:31.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The site footer revision number changes from v3.7.0 to v3.7.1 while the study page remains inaccessible.
    Difference
    0.2%
    Check dated 2026-10-11T20:42:51.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the usual study details and navigation. This blocks access to trial information that users expect to find on the page.
    Difference
    20%
    Check dated 2026-09-20T22:34:15.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Revision updated from v3.6.5 to v3.6.6, indicating a minor update to the page’s documentation/versioning. There are no changes to the study content or user-facing information.
    Difference
    0.1%
    Check dated 2026-08-30T19:54:41.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Adds Publications references from PubMed and a Publications section to the study record. It also lists the Principal Investigator (Jin Li), Shanghai East Hospital as a location, and sponsor and collaborators, enriching the institutional context of the study.
    Difference
    56%
    Check dated 2026-08-16T15:21:55.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    The page now shows revision v3.6.5, replacing v3.6.4, indicating a refreshed version of the page. This appears to be a minor maintenance update rather than a change to the study data or user-facing content.
    Difference
    0.1%
    Check dated 2026-08-09T09:10:45.000Z thumbnail image

Stay in the know with updates to Fruquintinib and Sintilimab in Advanced Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fruquintinib and Sintilimab in Advanced Solid Tumors Clinical Trial page.